92001E0191

WRITTEN QUESTION E-0191/01

by Chris Davies (ELDR) to the Commission

(1 February 2001)

Subject: Use of organophosphates on aircraft

Is the Commission aware of concern that air crews and travellers may suffer health problems because of the leakage into air-circulation systems on aircraft of fumes containing organophosphates, particularly tricreslyphosphate and triorthocresylphosphate used as lubricants in aircraft engines?

Is the Commission aware of any research being carried out into these alleged problems, and does it intend to submit proposals designed to reduce any proven or feared risks?

Joint answer to Written Questions E-0151/01, E-0155/01, E-0191/01, E-0233/01, E-0349/01 and P-0353/01 given by Mrs de Palacio on behalf of the Commission

(15 March 2001)

The Commission is well aware of recent reports and developments in the field of deep vein thrombosis (DVT) and cabin conditions, and is taking passengers' concerns very seriously. It has examined various reports, in particular that of the Select Committee on Science and Technology of the House of Lords.

On the basis of a preliminary assessment, the Commission has not found real substance in the extreme claims about health risks from air travel. However, it takes the danger of health risks most seriously, in particular that of DVT, the more so as data is poor on the incidence of the complaint.

Consequently, as a first precaution, the Commission sent a letter to the presidents of the Association of European Airlines, the European Regions Airlines Association and the International Air Carrier Association, urging their members to take precautionary measures in relation to DVT. In this letter, airlines were urged to act rapidly to minimise the risks by informing passengers when they make reservations or order tickets, on the risks, on predisposing factors and on precautionary measures to take before long flights and advise them, once on board the aircraft, on what to do to lessen the chance of thrombosis.

A number of airlines have already introduced, on their own initiative, pre-boarding warnings and/or in-flight advice (leaflets, videos, in-flight magazines showing exercises, recommending what to do and what to avoid, etc).

The next thing is to obtain balance assessments of health risks. The Commission will, as soon as possible, set up expert groups, one on the effects of DVT and the other on air quality and cabin conditions. They will scrutinise existing research and then draw conclusions on risks to health, the need for further research and on measures that the different actors involved should take.